Bulevirtide monotherapy in patients with chronic HDV: efficacy and safety results through week 96 from a phase III randomized trial - Wedemeyer, Heiner; Aleman, Soo; Brunetto, Maurizia; Blank, Antje; Andreone, Pietro; Bogomolov, Pavel; Chulanov, Vladimir; Mamonova, Nina; Geyvandova, Natalia; Morozov, Viacheslav; Sagalova, Olga; Stepanova, Tatyana; et al. (Journal of hepatology, 2024)
Gesehen am 04.06.2025